Intrinsiqq
Transcat Inc. logo

Transcat Inc. Insider Trading

TRNS

⊜ Compare
Last 12 months

Insiders bought 99K and sold 673K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Oksana S. Dominach sold 626K on Sep 2, 63% of their stake, outside a plan.

Net open-market
−575K
1 buy · 2 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
1 / 2
executives and directors
Last open-market buy
Aug 2026
Aug 6, 2026

Get an email when TRNS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 2No plan
    Oksana S. Dominach
    Director · sold 7,312 at $85.60
    626K
    63% of stake
  • Aug 7No plan
    Christopher P. Gillette
    Director · sold 504 at $94.23
    47K
    72% of stake
  • Aug 6
    Craig D. Cairns
    Director · bought 1,050 at $93.97
    99K
    14% of stake
  • Jan 31, 2025
    Craig D. Cairns
    Director · bought 1,200 at avg $77.02
    92K
    22% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TRNS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Instruments For Meas & Testing of Electricity & Elec Signals · Pick stocks to compare with TRNS

CompareIntrinsic value
COHUCohu Inc.
$43.98-12.09%16
ALNTAllient Inc
$79.56-9.61%31
INTTIntest Corporation
$14.00-4.63%4
FEIMFrequency Electronics, Inc.
$61.52-7.61%44
AEHRAehr Test Systems
$60.84-6.56%13
ITRIItron Inc.
$101.60+3.44%75
KEQUKewaunee Scientific Corporation
$34.23+1.18%64
MLABMesa Laboratories Inc.
$126.19+0.57%59

Held by ETFs

TRNS is in 24 US ETFs. The largest of them, with TRNS's weight in each:

Spot a number that looks wrong? Check it in TRNS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing TRNS

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.